EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy

Zhengzheng Fu, Lina Zhang, Rongyi Chen, Jipang Zhan, Jing Zhong, Wen Zheng, Jingwen Zou, Peng Wang, Xiaohua Deng, Alexander Y Lin, Daisy Dandan Wang, Peter Ping Lin und 1 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Letters, 2024. Verfasst von Zhengzheng Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatologic Surgery and Dermatologic Oncology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology H…. Hauptthemen laut MEDLINE: Aneuploidy, Endothelial Cells, Margins of Excision, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An optimum safety excision margin (EM) delineated by precise demarcation of field cancerization along with reliable biomarkers that enable predicting and timely evaluating patients' response to immunotherapy significantly impact effective management of melanoma. In this study, optimized biphasic "immunofluorescence staining integrated with fluorescence insitu hybridization" (iFISH) was conducted along the diagnosis-metastasis-treatment-cellular MRD axis to longitudinally co-detect a full spectrum of intact CD31- aneuploid tumor cells (TCs), CD31+ aneuploid tumor endothelial cells (TECs), viable and necrotic circulating TCs (CTCs) and circulating TECs (CTECs) expressing PD-L1, Ki67, p16 and Vimentin in unsliced specimens of the resected primary tumor, EM, dissected sentinel lymph nodes (SLNs) and peripheral blood in an early-stage melanoma patient. Numerous PD-L1+ aneuploid TCs and TECs were detected at the conventional safety EM (2 cm), quantitatively indicating the existence of a field cancerized EM for the first time. Contrary to highly heterogeneous PD-L1 expression and degrees of Chr8 aneuploidy in TCs and TECs in the primary lesions as well as CTCs and CTECs in peripheral blood, almost all TCs and TECs in SLNs and EM were homogeneously PD-L1+ haploid cells. Dynamic monitoring and cellular MRD assessment revealed that, in contrast to PD-L1+ CTCs being responsive to the immune checkpoint inhibitor (ICI-anti-PD-1), multiploid (≥pentasomy 8) PD-L1+ and Ki67+ CTECs were respectively resistant to ICI-sensitized T cells. In therapeutically stressed lymphatic and hematogenous metastatic cascades, stratified phenotypic and karyotypic profiling of iFISH tissue and liquid biopsied TCs, TECs, CTCs and CTECs in future large-cohort studies will enable appropriate re-specification of the optimal safety EM and distribution mapping of in-depth characterized, subcategorized target cells to help illustrate their metastatic relevance, ultimately improving risk stratification and clinical intervention of tumor progression, metastases, therapy resistance and cancer relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidyEndothelial CellsMargins of ExcisionMelanomaHumansB7-H1 AntigenBiomarkers, TumorImmunotherapyIn Situ Hybridization, FluorescenceNeoplastic Cells, CirculatingPlatelet Endothelial Cell Adhesion Molecule-1Skin Neoplasms

Stichwörter der Autor:innen

Aneuploid CTCs and CTECsCellular MRDQuantified field cancerizationSafety excision marginiFISH tumor tissue and liquid biopsies

Substanzen

B7-H1 AntigenBiomarkers, TumorCD274 protein, humanPECAM1 protein, humanPlatelet Endothelial Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Department of Dermatologic Surgery and Dermatologic Oncology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, Guangzhou, China.
  • Department of Cellular and Molecular Biology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Division of Cutaneous Oncology, Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, Guangzhou, China.
  • Department of Pathology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, Guangzhou, China.
  • Cytelligen, San Diego, CA, USA.
  • Cytelligen, San Diego, CA, USA. Electronic address: plin@cytelligen.com.

Förderung

  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Fu, Z., Zhang, L., Chen, R., Zhan, J., Zhong, J., Zheng, W., Zou, J., Wang, P., Deng, X., Lin, A. Y., Wang, D. D., Lin, P. P., & He, R. (2024). Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217099

Vancouver

Fu Z, Zhang L, Chen R, Zhan J, Zhong J, Zheng W, et al. Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217099

BibTeX
@article{Fu2024,
  author = {Fu, Zhengzheng and Zhang, Lina and Chen, Rongyi and Zhan, Jipang and Zhong, Jing and Zheng, Wen and Zou, Jingwen and Wang, Peng and Deng, Xiaohua and Lin, Alexander Y and Wang, Daisy Dandan and Lin, Peter Ping and He, Renliang},
  title = {Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217099}
}
Kostenlos starten →